CureApp, Inc.

Overview

CureApp, Inc. is a Japanese MedTech company focused on developing and distributing evidence-based Digital Therapeutics (DTx). Headquartered in Tokyo, the company specializes in creating software applications classified as medical devices to address conditions where traditional treatments may be insufficient. Scientific validation and patient-centered solutions are central to its approach, merging technology with healthcare innovation.

Clinically validated prescription DTx apps are among its offerings, including Japan's first approved nicotine addiction treatment app and the world's first standalone software for hypertension. CureApp also delivers corporate healthcare programs that implement mobile health solutions in various organizations, striving for global expansion through subsidiaries and partnerships. Notable achievements include regulatory approvals and recognition as a leader in digital health.

Basic Information

Contact Details

• Website: cureapp.co.jp
• LinkedIn: linkedin.com/company/cureapp-inc

Key Focus Areas & Initiatives

• Digital healthcare
• Self-management for chronic diseases
• Evidence-based Digital Therapeutics (DTx)
• Medical mobile applications
• Behavioral science and therapy
• Mobile healthcare solutions
• Smoking cessation app
• Telemedicine
• Healthcare innovation and outcomes
• Health data analytics
• Clinical efficacy and research
• Hypertension management app
• Corporate healthcare programs
• Remote patient monitoring
• Medical device software development
• Alcohol dependence treatment
• IoT integration in healthcare
• Digital health trials
• Patient management

Technologies Used

• Amazon AWS
• Deel
• Google Tag Manager
• Mobile Friendly
• Route 53

Affiliated Organizations & Regional Branches